Fortrea Holdings Past Earnings Performance
Past criteria checks 0/6
Fortrea Holdings has been growing earnings at an average annual rate of 22.6%, while the Life Sciences industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 2.4% per year.
Key information
22.6%
Earnings growth rate
-269.2%
EPS growth rate
| Life Sciences Industry Growth | 12.9% |
| Revenue growth rate | 2.4% |
| Return on equity | -14.7% |
| Net Margin | -7.1% |
| Next Earnings Update | 08 Nov 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fortrea Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3,015 | -215 | 398 | 0 |
| 31 Mar 24 | 3,077 | -91 | 340 | 0 |
| 31 Dec 23 | 3,109 | -3 | 337 | 0 |
| 30 Sep 23 | 2,957 | 53 | 357 | 0 |
| 30 Jun 23 | 2,943 | 127 | 349 | 0 |
| 31 Mar 23 | 3,011 | 168 | 322 | 0 |
| 31 Dec 22 | 3,096 | 193 | 280 | 0 |
| 31 Dec 21 | 3,058 | 98 | 303 | 0 |
| 31 Dec 20 | 2,580 | -359 | 268 | 0 |
Quality Earnings: FTRE1 * is currently unprofitable.
Growing Profit Margin: FTRE1 * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FTRE1 * is unprofitable, but has reduced losses over the past 5 years at a rate of 22.6% per year.
Accelerating Growth: Unable to compare FTRE1 *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FTRE1 * is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4%).
Return on Equity
High ROE: FTRE1 * has a negative Return on Equity (-14.75%), as it is currently unprofitable.